These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 21305522

  • 1. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
    Glant TT, Radacs M, Nagyeri G, Olasz K, Laszlo A, Boldizsar F, Hegyi A, Finnegan A, Mikecz K.
    Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
    [Abstract] [Full Text] [Related]

  • 2. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
    Markovics A, Ocskó T, Katz RS, Buzás EI, Glant TT, Mikecz K.
    PLoS One; 2016 May; 11(7):e0160284. PubMed ID: 27466816
    [Abstract] [Full Text] [Related]

  • 3. The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.
    Misják P, Bősze S, Horváti K, Pásztói M, Pálóczi K, Holub MC, Szakács F, Aradi B, György B, Szabó TG, Nagy G, Glant TT, Mikecz K, Falus A, Buzás EI.
    Immunol Lett; 2013 Apr; 152(1):25-31. PubMed ID: 23578666
    [Abstract] [Full Text] [Related]

  • 4. An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.
    Mikecz K, Glant TT, Markovics A, Rosenthal KS, Kurko J, Carambula RE, Cress S, Steiner HL, Zimmerman DH.
    Vaccine; 2017 Jul 13; 35(32):4048-4056. PubMed ID: 28583308
    [Abstract] [Full Text] [Related]

  • 5. Recombinant Human Proteoglycan Aggrecan-G1 Domain-induced Arthritis (GIA) Mouse Model.
    Olasz K, Boldizsar F.
    Curr Protoc; 2024 May 13; 4(5):e1053. PubMed ID: 38752927
    [Abstract] [Full Text] [Related]

  • 6. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT, Mikecz K.
    Methods Mol Med; 2004 May 13; 102():313-38. PubMed ID: 15286393
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model.
    Ishikawa LL, Colavite PM, da Rosa LC, Balbino B, França TG, Zorzella-Pezavento SF, Chiuso-Minicucci F, Sartori A.
    Biomed Res Int; 2014 May 13; 2014():148594. PubMed ID: 24971313
    [Abstract] [Full Text] [Related]

  • 9. T cell receptor (TCR) signal strength controls arthritis severity in proteoglycan-specific TCR transgenic mice.
    Olasz K, Boldizsar F, Kis-Toth K, Tarjanyi O, Hegyi A, van Eden W, Rauch TA, Mikecz K, Glant TT.
    Clin Exp Immunol; 2012 Feb 13; 167(2):346-55. PubMed ID: 22236012
    [Abstract] [Full Text] [Related]

  • 10. Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.
    Angyal A, Egelston C, Kobezda T, Olasz K, László A, Glant TT, Mikecz K.
    Arthritis Res Ther; 2010 Feb 13; 12(2):R44. PubMed ID: 20298547
    [Abstract] [Full Text] [Related]

  • 11. Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan.
    Murad YM, Szabó Z, Ludányi K, Glant TT.
    Clin Exp Immunol; 2005 Nov 13; 142(2):303-11. PubMed ID: 16232217
    [Abstract] [Full Text] [Related]

  • 12. Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis.
    Olalekan SA, Cao Y, Finnegan A.
    Arthritis Res Ther; 2014 Sep 25; 16(5):440. PubMed ID: 25253467
    [Abstract] [Full Text] [Related]

  • 13. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice.
    Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT.
    Int Immunol; 2009 May 25; 21(5):511-22. PubMed ID: 19254958
    [Abstract] [Full Text] [Related]

  • 14. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE, Guichelaar T, Ten Brink CB, van Kooten PJ, Hauet-Broeren F, Ludanyi K, van Eden W, Broeren CP, Glant TT.
    Arthritis Rheum; 2006 Aug 25; 54(8):2423-33. PubMed ID: 16869010
    [Abstract] [Full Text] [Related]

  • 15. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.
    Bárdos T, Czipri M, Vermes C, Zhang J, Mikecz K, Glant TT.
    Clin Exp Immunol; 2002 Aug 25; 129(2):224-31. PubMed ID: 12165077
    [Abstract] [Full Text] [Related]

  • 16. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis.
    Kaplan C, Valdez JC, Chandrasekaran R, Eibel H, Mikecz K, Glant TT, Finnegan A.
    Arthritis Res; 2002 Aug 25; 4(1):54-8. PubMed ID: 11879537
    [Abstract] [Full Text] [Related]

  • 17. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
    Zhang J, Bárdos T, Mikecz K, Finnegan A, Glant TT.
    J Immunol; 2001 Apr 15; 166(8):4981-6. PubMed ID: 11290777
    [Abstract] [Full Text] [Related]

  • 18. Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.
    Hanyecz A, Olasz K, Tarjanyi O, Nemeth P, Mikecz K, Glant TT, Boldizsar F.
    Biomed Res Int; 2014 Apr 15; 2014():942148. PubMed ID: 24605340
    [Abstract] [Full Text] [Related]

  • 19. Development of inflammation in proteoglycan-induced arthritis is dependent on Fc gamma R regulation of the cytokine/chemokine environment.
    Kaplan CD, O'Neill SK, Koreny T, Czipri M, Finnegan A.
    J Immunol; 2002 Nov 15; 169(10):5851-9. PubMed ID: 12421967
    [Abstract] [Full Text] [Related]

  • 20. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
    Hanyecz A, Berlo SE, Szántó S, Broeren CP, Mikecz K, Glant TT.
    Arthritis Rheum; 2004 May 15; 50(5):1665-76. PubMed ID: 15146438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.